SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001571049-17-003097
Filing Date
2017-03-31
Accepted
2017-03-31 17:18:41
Documents
5
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT t1700920-prem14a.htm PREM14A 2605163
2 GRAPHIC lg_caladrius.jpg GRAPHIC 208381
3 GRAPHIC sg_mts-securities.jpg GRAPHIC 26375
4 GRAPHIC t1700920_pc01.jpg GRAPHIC 670746
5 GRAPHIC t1700920_pc02.jpg GRAPHIC 261773
  Complete submission text file 0001571049-17-003097.txt   4196204
Mailing Address 106 ALLEN ROAD FOURTH FLOOR BASKING RIDGE NJ 07920
Business Address 106 ALLEN ROAD FOURTH FLOOR BASKING RIDGE NJ 07920 908-842-0100
Caladrius Biosciences, Inc. (Filer) CIK: 0000320017 (see all company filings)

IRS No.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-33650 | Film No.: 17731391
SIC: 8090 Services-Misc Health & Allied Services, NEC
Assistant Director 9